By Chris Wack Portage Biotech shares were up 20% to $2.81 after the company entered into a clinical trial collaboration agreement with Merck to evaluate.
Portage Biotech (NASDAQ:PRTG) Rating Reiterated by Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.